Acknowledgments
Funding for this study was provided by Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., and Incyte Corporation. The authors wish to thank the patients, investigators, and site personnel who participated in this study. Pharmacokinetic analysis was performed by April M. Barbour of Incyte Corporation. Medical writing assistance was provided by Matthew Bidgood, of Envision Pharma Group, and funded by Incyte Corporation.
